We forecast continued robust growth in medicine sales over the short term, while in the longerterm we anticipate that greater pricing controls will be enforced to reduce this high-sales growth. This is nline with two key trends in the Central Europe and Baltics region: the expansion of medicine reimbursementand greater emphasis on spending efficiency.
Headline Expenditure Projections
Pharmaceuticals: Pharmaceutical spending will rise from EUR331mn (USD366mn) in 2016 toEUR361mn (USD397mn) in 2017, up 9.1% in local currency terms and up 8.5% in US dollar terms.
Forecast increased from last quarter.
Healthcare: Spending will rise from EUR1.38bn (USD1.53bn) in 2016 to EUR1.45bn (USD1.60bn) in2017, up 4.9% in local currency terms, but down 4.3% in US dollar terms. Forecast increased from lastquarter.
According to the Estonian Agency of Medicines, in Q1 2017 the medicinal products market increased3.4%, reaching EUR75.6mn (USD89mn). Prescription sales accounted for 85% of the total.